Current pandemic caused by infection with Coronavirus 2019 is causing unprecedented global health crisis. The vulnerability of pregnant women to infections as well as the experience of previous coronavirus epidemics have raised questions about the risks of maternal-fetal complications. The first data in the literature suggest treatment similar to that of the general population. However, the speed with which the infection progressed, as well as the uncertainty of its impact on pregnancy due to the lack of solid scientific data, has forced obstetricians to adapt their practice based on pragmatic attitudes. This article reviews the obstetrical management of patients infected with SARS-COV-2 in the northern region of Morocco on the basis of current knowledge.
Subcapsular hepatic haematoma is a rare complication of preeclampsia occurring mainly in the context of HELLP syndrome, it is associated with a high mortality or morbidity rate. An early diagnosis before the break point of the hematoma and a multidisciplinary proper care is mandatory.We report one case of cracked subcapsular hematoma liver collected at the Hospital of Maternity Souissi Rabat, with a favourable evolution that was observed after surgical management limited to hepatic packing and transfusion.
Ovarian vein thrombophlebitis is a rare complication that must be evoked and sought, Paticularly in front of the persistance of a febrile abdomonal pain syndrome, before childbirth, postpartum and also in postabortum.The imaging means, we currently have, especially the doppler echo, computed tomography (TDM) and magnetic reasoning imagin (IRM) allow us to make this diagnosis and choose the most suitable treatment.
The spontaneous rupture of uterine varicose veins during pregnancy and more particularly in the third trimester, is an exceptional cause of hemorrhagic shock by hemoperitoneum. Its diagnosis is difficult due to its rarity and the absence of specific signs. Maternal-fetal care must be immediate in order to reduce high fetal mortality and limit maternal morbidity.
Ovarian carcinosarcoma also known as mixed mesodermal tumor or mixed Mullerian tumor is a rare gynecological tumor that accounts for less than 2% of ovarian cancers. It is an aggressive tumor which combines a carcinomatous component with a sarcomatous component. In the genital tract, it most often sits in the uterus. The ovary, cervix or vagina are more rarely affected. Carcinosarcoma interests women rather between 60 and 70 years of age. The main prognostic factor found is the initial stage, most often advanced: At diagnosis, more than 90% of ovarian carcinosarcomas have an extra-ovarian extension.Surgical management is a determining factor for the survival of patients. Carcinosarcoma is an aggressive tumor, the median survival is 7 to 27 months for ovarian carcinosarcomas. Relapses mainly occur in the first year. The FIGO stage is the most important prognostic factor.Complete surgery, advanced age, the grade of the sarcomatous component and adjuvant chemotherapy are found in the rare published retrospective studies. The response rate to chemotherapy is approximately 20%.
Show abstract
Full Text
